NCT06058156 Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT06058039 Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06058013 Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06056596 Lamivudine and Plasma Markers of Inflammation in Retinal Detachment Status TERMINATED Phase EARLY_PHASE1
NCT06056297 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections Status RECRUITING Phase PHASE3
NCT06055777 Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts Status TERMINATED Phase PHASE1
NCT06055452 Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension Status RECRUITING Phase PHASE4
NCT06055374 A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis Status WITHDRAWN Phase PHASE1
NCT06055361 A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis Status RECRUITING Phase PHASE1
NCT06055179 XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial) Status RECRUITING Phase NA
NCT06053814 NS-050/NCNP-03 in Boys With DMD (Meteor50) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06053580 Repurposing Valsartan May Protect Against Pulmonary Hypertension Status RECRUITING Phase PHASE2
NCT06052696 Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL Status NOT_YET_RECRUITING Phase PHASE4
NCT06051617 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Status RECRUITING Phase PHASE3
NCT06051240 Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy Status RECRUITING Phase PHASE2
NCT06050577 The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06049147 Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers Status COMPLETED Phase PHASE1